Relation between radionuclide angiographic regional ejection fraction and left ventricular regional ischemia in awake dogs

Multigated equilibrium radionuclide angiography was used to quantitate global and regional ejection fraction (EF) in 26 awake dogs 10 minutes after distal and then proximal occlusion of the left anterior descending (LAD) or left circumflex (LC) coronary artery. Changes in global and regional EF were correlated with simultaneous measurements of the extent of acute left ventricular (LV) ischemia measured by radioisotope-labeled microspheres. The extent of ischemia, defined as the percentage of LV mass with greater than 25% reduction in blood flow from normal regional flow, was linearly related to the percent change in global EF after LAD (r = 0.84) and LC (r = 0.77) occlusions. The extent of ischemia also correlated with regional EF (r = 0.47 to 0.88 for LAD and r = 0.41 to 0.69 for LC occlusions). In 24 of 25 LAD occlusions and in all 20 LC occlusions that produced a measurable ischemic zone, the maximal percent change in regional EF exceeded the percent change in global EF. Two LAD occlusions and 2 LC occlusions reduced regional EF but not global EF. Thus, global and regional EF decreased in direct proportion to the extent of acute myocardial ischemia; regional ischemia produced greater changes in regional than in global EF.     

Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise

The effects of oral prazosin (PZ), 15 to 20 mg/day, on symptoms, exercise performance and left ventricular (LV) function were assessed in a 6-month, double-blind, placebo-controlled study of patients in New York Heart Association functional class III. Ejection fraction (EF) was measured at rest and during upright bicycle exercise by equilibrium radionuclide angiography; end-diastolic volume, stroke volume and cardiac output were derived from corresponding count measurements. Although there was no statistically significant difference between clinical responses in the prazosin and placebo groups, qualitative differences suggested a clinical response to prazosin. Of the 9 patients who received PZ, 5 improved to functional class II and 2 became asymptomatic; the 2 nonresponders deteriorated to functional class IV when PZ was stopped. Four of 9 patients who received placebo improved to functional class II and 2 deteriorated to class IV. Exercise time tended to increase in the prazosin group (from 541 ± 204 to 630 ±100 seconds at 6 months) and decrease in the placebo group (from 539 ± 141 to 435 ±148 seconds at 6 months), but neither change was significant. Prazosin effected a sustained decrease in mean blood pressure of approximately 10 mm Hg at rest, and a quantitatively similar but insignificant decrease during exercise. Radionuclide EF increased and LV end-diastolic counts decreased significantly at rest and during exercise in the prazosin group, but not in the placebo group. Because changes in EF and end-diastolic counts were similar, stroke counts and count output were unchanged. Thus, long-term oral PZ therapy caused sustained changes in blood pressure and LV function in most patients in functional class III, but these changes were not uniformly translated into clinical improvement or increased exercise tolerance. Prazosin does not appear to increase cardiac output during exercise in patients with heart failure.     

Relation between regional distribution of thallium-201 and myocardial blood flow in normal,acutely ischemic,and infarcted myocardium

Myocardial localization of thallium-201 was compared with direct measurements of myocardial perfusion in normal, acutely ischemic, and recently infarcted myocardium. Studies were performed in 6 chronically instrumented dogs that were subjected to myocardial infarction by occlusion of the proximal left circumflex coronary artery. Four days after myocardial infarction, thallium-201 and 9 ± 1 μm niobium-95-labelled microspheres were injected simultaneously after acute left anterior descending coronary arterial occlusion; the animals were killed 5 minutes later and the entire left ventricle was sectioned into 1 to 2 g samples. Regression analyses between thallium-201 activity and regional myocardial blood flow using all myocardial samples demonstrated a very close linear relation in each dog; r values were 0.98 or greater, indicating that the initial localization of thallium-201 in acutely ischemic and recently infarcted myocardium as a function of regional blood flow was essentially identical. Consequently, in each dog the regional distribution of thallium-201 closely approximated myocardial perfusion over a wide range of blood flow and potentially different local metabolic conditions that may be encountered in the clinical use of the isotope.     

Importance of complete revascularization in performance of the coronary bypass operation

Cardiac Data Bank records of 1,238 patients with triple-vessel disease (greater than or equal to 50% diameter reduction) who had undergone coronary bypass surgery were reviewed and divided into 2 groups depending on whether complete (n = 773) or incomplete (n = 465) revascularization had been accomplished. Patients with complete revascularization had a higher incidence of a normal preoperative electrocardiogram than did patients with incomplete revascularization (23 versus 14%, respectively, p less than 0.0001). The ejection fraction for both completely and incompletely revascularized patients was good (m = 0.60 and 0.57, respectively). The mean number of grafts per patient for the 2 groups was 3.8 and 2.6 (p less than 0.0001). There was no significant difference between the 2 groups with regard to postoperative inotropic requirements (8 and 7%), ventricular arrhythmias (1.8 and less than 1%), necessity for intraaortic balloon pumping (1.6 and 1.5%, hospital mortality (1.2 and 2.8%), or myocardial infarction (4.3 and 4.8%). Survival at 5 years was significantly greater (p less than 0.001) in patients with complete (88.5%) than in those with incomplete revascularization (83.5%). Reemployment occurred more often in patients with complete (52%) than in those with incomplete revascularization (40%) (p less than 0.001), and more patients were free of angina after complete (70%) than after incomplete revascularization (58%) (p less than 0.0005). Long-term survival appeared to be mediated primarily through improved revascularization rather than through differences in left ventricular function.     

Anatomic and prognostic implications of an early positive treadmill exercise test

Eighty men (group A) with clinical coronary artery disease underwent coronary angiography regardless of symptoms and previous therapy because they had a positive treadmill exercise test in stage I or II of the Bruce protocol. Thirty-four other men (group B) who also had an early positive treadmill test underwent coronary angiography because they had disabling angina pectoris despite medical therapy. We found left main coronary artery stenosis of 50% or greater of the vessel diameter in 28% of group A and 35% of group B (p >0.3). In contrast, only 10% of 93 other catheterized patients who had treadmill tests that were not early positive had left main coronary disease (p < 0.001). Fifty-four patients from group A who did not have left main stenosis of 50% or greater were treated medically. In this subgroup, 85% had 2 or 3 major coronary vessels with 75% or greater stenosis. These patients had a 36 month survival rate of 89.2%.We conclude that an early positive treadmill test identifies patients who have an increased likelihood of having left main coronary stenosis, even if they are minimally symptomatic. To identify left main coronary stenosis, catheterization may be justified in patients whose angina pectoris has been mild or not intensively treated when they have an early positive treadmill response. After left main coronary stenosis has been excluded, these patients may be treated medically with a low mortality.     

Assessment of left ventricular function by resting and exercise radionuclide angiocardiography following acute myocardial infarcton

Left ventricular function was evaluated by first-pass radionuclide angiocardiography in 42 patients at 3 and 8 weeks following acute myocardial infarction. Left ventricular ejection fraction, diastolic volume, and wall motion were measured at rest and submaximal exercise at 3 weeks and at rest, submaximal and maximal exercise at 8 weeks. The mean ejection fraction, end-diastolic volume, and wall motion index did not change between 3 and 8 weeks in any group either at rest or during submaximal exercise. Ventricular function was decreased at rest in patients with previous and anterior myocardial infarction, but not in patients with inferior and subendocardial myocardial infarctions. During maximal exercise at 8 weeks, nine patients (21%) had ST segment depression, whereas 25 patients (60%) had a decrease in ejection fraction or a deterioration in wall motion. These abnormalities of ventricular function during exercise occurred equally among the infarct groups. Radionuclide angiography in patients with recent myocardial infarction demonstrated highly variable ventricular function at rest and/or during exercise in each infarct subgroup.     

Detection of left ventricular thrombi with radionuclide angiography

Apparent filling defects compatible with left ventricular thrombus are occasionally noted in equilibrium radionuclide angiocardlograms. To define the usefulness of the radionuclide angiogram in detecting left ventricular thrombus, the anterior and left anterior oblique radionuclide angiograms of 39 patients with proved presence or absence of thrombus were blindly interpreted. The presence of thrombus was proved at autopsy in 5 patients, at cardiac operation in 2, or on indium-111 platelet imaging in 6; the absence of thrombus was proved at autopsy in 24 or at cardiac operation in 2. Overall, 13 radionuclide angiograms were interpreted as posltive (n = 10) or equivocally positive (n = 3) for thrombus, and 26 studies were judged negative. The sensitivity of a positive or equivocally positive radionuclide angiogram for detection of thrombus was 77 percent (10 of 13 patients), the specificity 88 percent (23 of 26 patients), the positive predictive value 77 percent, the negative predictlve value 88 percent. If the three equivocal studies are instead considered negative for thrombus, the sensitivity was 62 percent, the specificity 92 percent, the positive predictive value 80 percent and the negative predictive value 93 percent. All thrombi were visualized in the anterior view in an area of akinetic or dyskinetic wall motion. A small group of 13 patients (8 with thrombus, 5 without) underwent two dimenslonal echocardiography, which was 100 percent sensitive and specific. The finding of a discrete filling defect or squared or cutoff ventricular apex in an area of abnormal wall motion in the anterior view of the radionuclide angiogram should suggest the diagnosis of ventricular thrombus, which may be confirmed by other noninvasive studies.     

Quantitative radionuclide angiography in the right anterior oblique view: Comparison with contrast ventriculography

Because the right anterior oblique view is widely accepted as the best “single” projection for assessing wall motion, the utility of this view during first pass radionuclide angiography was studied in 44 patients who also underwent contrast ventriculography and coronary arteriography. Of the 44 patients, 8 had a normal heart and 14 had coronary artery disease with normal wall motion on contrast ventriculography. All also had normal contraction on radionuclide angiography. On contrast ventriculography, 22 patients had coronary artery disease and asynergy involving 34 left ventricular segments. Of 17 segments localized to the anterior and apical asynergic areas on contrast ventriculography, 16 were accurately localized with radionuclide angiography. Similarly, of 17 inferior asynergic areas, 13 were also shown to be inferior on radionuclide angiography. In addition, quantitative assessment of the severity of asynergy using the hemiaxis method demonstrated a good correlation between asynergic severity as defined with radionuclide angiography and contrast ventriculography. Of 11 anterior areas, 7 defined as hypokinetic with contrast ventriculography demonstrated chordal shortening of 20.1 ± 5.2 percent (mean ± standard error of the mean) (P < 0.005 compared with normal) on radionuclide angiography. Similarly, four akinetic or dyskinetic segments on contrast ventriculography demonstrated a greater reduction (4.0 ± 4.0 percent) in chordal shortening on radionuclide angiography (P < 0.05 compared with hypokinetic segments). Akinetic apical and inferior segments as defined with contrast ventriculography also showed a marked reduction in wall motion to 10.4 ± 7.3 percent and 7.5 ± 4.1 percent, respectively.After appropriate background subtraction, determination of ejection fraction using radionuclide angiography showed a correlation of 0.839 between the left anterior oblique and right anterior oblique projections independent of the sequence of injection. In addition, ejection fraction determined with radionuclide angiography in the left (r = 0.824) and right (r = 0.801) anterior oblique views correlated well with ejection fraction assessed from contrast ventriculography. Thus, first pass radionuclide angiography performed in the right anterior oblique view is a sensitive noninvasive means of assessing the location and severity of asynergy as well as global left ventricular performance in patients with coronary artery disease.     

Effects of exercise training on left ventricular function in normal subjects: A longitudinal study by radionuclide angiography

Radionuclide angiocardiography provides accurate hemodynamic information during maximal exercise in erect subjects. Cardiac function was studied with this noninvasive technique in 12 male and 6 female college athletes before (BT) and after (AT) 6 months of swimming training. Measurements at rest and during maximal exercise of heart rate, left ventricular ejection fraction, end-diastolic volume, cardiac output and total body blood volume were determined from first pass and equilibrium precordial counting techniques. The results were as follows:

     

13.

Effect of amiodarone on ventricular function as measured by gated radionuclide angiography   总被引：3，自引：0，他引：3  

G B Trobaugh  P J Kudenchuk  H L Greene  R C Tutt  E Kingston  J R Gorham  B W Gross  E L Graham  G K Sears  J A Werner 《The American journal of cardiology》1984,54(10):1263-1266

Myocardial size and contractility were measured by gated radionuclide ventriculography in 70 patients before and a mean of 66 days after beginning amiodarone therapy. The mean dose of amiodarone at the time of the second study was 481 mg. The mean left ventricular (LV) ejection fraction (EF) increased slightly, from 40% to 43% (p = 0.001). The mean right ventricular EF remained unchanged (38% to 39%, difference not significant [NS]). The LV end-diastolic volume (count-based method) increased by 9% (p = 0.01), but no change could be demonstrated for end-systolic volume (4%, NS). The LV stroke volume increased 19% (p = 0.001), but cardiac output remained unchanged (5%, NS) because the heart rate decreased by 9 beats/min (p = 0.001). The right ventricular end-diastolic volume increased by 12% (p = 0.01) and end-systolic volume increased by 11% (p = 0.03). Stroke volume increased by 18% (p = 0.005). There was no significant correlation between the change in LVEF and the pre-amiodarone LVEF, the time interval between studies, or with indexes of amiodarone effect (change in heart rate, QRS, QTc, TSH, amiodarone dosage). In 5 patients (7%), LVEF decreased significantly, requiring discontinuation of amiodarone therapy in 1 patient. At the time of the second study congestive heart failure was manifest in 19%, and there was a trend suggesting that congestive heart failure was more likely if the initial LVEF was less than or equal to 35% (p = 0.10). Thus, amiodarone may rarely adversely affect contractility, although myocardial contractility is typically unchanged. There is an associated small increase in the size of both ventricles.     

14.

Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease     

David B. Pryor  Frank E. Harrell  Kerry L. Lee  Robert A. Rosati  R.Edward Coleman  Frederick R. Cobb  Robert M. Califf  Robert H. Jones 《The American journal of cardiology》1984,53(1):18-22

     

15.

Hemodynamic effects of acute atrioventricular sequential pacing in patients with left ventricular dysfunction     

Michael J. Reiter  Michael C. Hindman 《The American journal of cardiology》1982,49(4):687-692

Acute atrioventricular (A-V) sequential pacing was compared with ventricular pacing in seven men with symptomatic left ventricular failure (New York Heart Association functional class III and IV) and depressed left ventricular ejection fraction (mean 29 percent, range 18 to 40). Cardiac index was higher during A-V sequential pacing than during ventricular pacing for every patient at paced rates of 75 to 100 beats/min. The mean increment was 17 percent (range 10 to 37) at a paced rate of 75 beats/ min, 23 percent (range 8 to 45) at a paced rate of 85 beats/min and 29 percent (range 19 to 55) at a paced rate of 100 beats/min. The increase in cardiac index in an individual patient did not correlate with baseline characteristics including functional class, cardiothoracic ratio, resting ejection fraction, cardiac index or balloon-occluded pulmonary wedge pressure.Arterial pressure varied from beat to beat during ventricular pacing because of the changing relation of atrial to ventricular systole. When an atrial contraction preceded a ventricular paced beat by a physiologic interval intraarterial pulse pressure uniformly increased. That increase correlated strongly (r = 0.993) with the increase in cardiac index that occurred during A-V sequential pacing. Measurement of the pulse pressure during A-V dissociation is a simple technique that may be useful for predicting the degree of improvement in cardiac output expected with methods of pacing that restore A-V synchrony.     

16.

Effects of disopyramide on left ventricular function: Assessment by radionuclide cineangiography     

John S Gottdiener  Robert Dibianco  Richard Bates  Bertram J Sauerbrunn  Ross D Fletcher 《The American journal of cardiology》1983,51(9):1554-1558

To determine the effects of disopyramide on resting systolic left ventricular (LV) function and LV functional reserve, gated equilibrium radionuclide cineangiography was performed at rest and during maximal symptom-limited supine bicycle exercise in 12 patients after a single 300 mg oral loading dose of disopyramide, and in 22 patients (including the 12 patients just mentioned) after they received disopyramide 150 mg 4 times daily for 5 to 10 days (average 7). The oral loading dose (average serum level 3.6 ± 1.3 μg/ml [standard deviation]) produced decreases in ejection fraction in 9 of 12 patients with a decrease in average resting ejection fraction from 40 ± 15% to 33 ± 11% (p <0.005). However, the lower, sustained dosage of disopyramide was associated with a lower average serum level of 2.5 ± 0.8 μg/ml and with smaller but significant decreases in ejection fraction in 3 of 22 patients during exercise only. At this dosage there was no significant decrease in average ejection fraction for the group at rest or during exercise. Adverse effects of disopyramide on ejection fraction occurred even in patients with previously normal LV function at rest. Hence, disopyramide may be associated with significant decreases in LV systolic function, particularly when given in high, oral “loading” doses. However, sustained therapy with lower dosages as well as lower drug levels is also associated with less depression of LV function.     

17.

Effect of different epicardial ventricular pacing sites on left ventricular function in awake dogs     

A Walston  J W Starr  J C Greenfield 《The American journal of cardiology》1973,32(3):291-294

     

18.

Noninvasive diagnosis of left ventricular pseudoaneurysm: role of two dimensional echocardiography and radionuclide gated pool imaging.     

R J Katz  A Simpson  R DiBianco  R D Fletcher  H R Bates  B J Sauerbrunn 《The American journal of cardiology》1979,44(2):372-377

This report describes a case of left ventricular pseudoaneurysm diagnosed with two dimensional real time echocardiography. The two dimensional echocardiogram identified not only the pseudoaneurysmal sac but also the site of left ventricular rupture. When supplemented with radioisotope gated cardiac blood pool scanning, the noninvasive studies demonstrated combined true and false left ventricular aneurysms. Left ventricular pseudoaneurysm can be diagnosed using two dimensional echocardiography and nuclear imaging, permitting early operative intervention before fatal rupture.     

19.

Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dog     

A K Dawson  D M Roden  H J Duff  R L Woosley  R F Smith 《The American journal of cardiology》1984,54(6):654-658

Encainide is highly effective in suppressing most nonsustained ventricular arrhythmias, but there is evidence that the drug is less effective and may worsen some arrhythmias, particularly in patients with sustained ventricular tachycardia. In most patients it is likely that the major antiarrhythmic effects of encainide are mediated through a potent metabolite, O-demethyl encainide. The effects of infusions of saline solution or O-demethyl encainide on spontaneous ventricular ectopic activity and ventricular fibrillation (VF) threshold were compared in 25 dogs with a mottled myocardial infarct produced by transient coronary occlusion. Plasma levels of the metabolite above 100 ng/ml suppressed (greater than 92%) the spontaneous ventricular ectopic activity that occurred 48 hours after MI, whereas saline solution had no effect. In 15 dogs treated with O-demethyl encainide, the VF threshold decreased an average of 23%, from a baseline level of 23 +/- 8 mA to 18 +/- 9 mA (p less than 0.05). There was a concentration-dependent fall in VF threshold with plasma concentrations of O-demethyl encainide above 150 ng/ml. In 2 dogs with very high plasma concentrations of the metabolite (greater than 1,000 ng/ml), VF was induced by right ventricular pacing alone (S1S1 300 ms). No change in VF threshold was observed in the 8 dogs treated with saline solution, and in each of these dogs VF could be terminated by the countershock protocol. However, in 7 of the 17 dogs treated with O-demethyl encainide, VF could not be terminated by the countershock protocol.(ABSTRACT TRUNCATED AT 250 WORDS)     

20.

Relation of left ventricular mass to geometry of the proximal coronary arteries in the dog     

Richard S. Stack MD  Judith C. Rembert PhD  Bruce Schirmer MD  Joseph C. Greenfield Jr. MD   《The American journal of cardiology》1983,51(10):1728-1731

Proximal epicardial coronary artery luminal diameters were measured from silicone casts formed in situ in freshly excised hearts under a constant pressure of 100 mm Hg. Twenty-five coronary arteries from 15 normal dogs and 22 coronary arteries in 13 dogs with either chronic pressure or volume overload hypertrophy were studied. Mean left ventricular (LV) body weight ratios were 4.75 ± 1.01 g/kg in the normal dogs, 8.4 ± 1.7 g/kg in the pressure-overload dogs, and 6.2 ± 0.6 g/kg in the volume-overload dogs. The cross-sectional area of the left circumflex (LC) coronary artery was determined at 11 branch sites. The ratio of the area of the branches to the area of the parent vessel was 1.095 ± 0.105, indicating that the cross-sectional area after a branch point increased.

A poor correlation existed between LV mass and coronary artery diameter in both normal and hypertrophy groups for the LC (r = 0.44), the left anterior descending (LAD) (r = 0.63), and the combined LC and LAD (r = 0.52). The mean cross-sectional area of the combined LC and LAD was 0.12 cm² in the normal group and 0.15 cm² in the hypertrophy group; this increase was not statistically significant (p = 0.13). When the mean cross-sectional area of the combined vessels was adjusted for heart weight, there was a decrease in the cross-sectional area/100 g of myocardium in the hypertrophy group compared with the control group. These data demonstrate that coronary artery luminal diameter in the dog does not increase commensurately with the increase in mass associated with myocardial hypertrophy.     

	Heart Rate (beats/ min)	Ejection Fraction (%)	End-Diastolic Volume (ml)	Cardiac Output (liters/ min)	Total Body Blood Volume (liter)
Rest
BT	$\text{74 ± 11}$	$\text{73 ± 6}$	$\text{133 ± 35}$	$\text{6.9 ± 1.1}$	$\text{8.7 ± 0.8}$
AT	$\text{61 ± 7}$	$\text{67 ± 7}$	$\text{167 ± 40}$	$\text{6.7 ± 1.0}$	$\text{11.4 ± 2.2}$
Exercise
BT	$\text{185 ± 10}$	$\text{87 ± 4}$	$\text{166 ± 34}$	$\text{25.5 ± 5.7}$	$\text{8.0 ± 0.9}$
AT	$\text{181 ± 14}$	$\text{86 ± 5}$	$\text{204 ± 39}$	$\text{32.0 ± 8.7}$	$\text{10.8 ± 2.3}$

Effect of amiodarone on ventricular function as measured by gated radionuclide angiography

Myocardial size and contractility were measured by gated radionuclide ventriculography in 70 patients before and a mean of 66 days after beginning amiodarone therapy. The mean dose of amiodarone at the time of the second study was 481 mg. The mean left ventricular (LV) ejection fraction (EF) increased slightly, from 40% to 43% (p = 0.001). The mean right ventricular EF remained unchanged (38% to 39%, difference not significant [NS]). The LV end-diastolic volume (count-based method) increased by 9% (p = 0.01), but no change could be demonstrated for end-systolic volume (4%, NS). The LV stroke volume increased 19% (p = 0.001), but cardiac output remained unchanged (5%, NS) because the heart rate decreased by 9 beats/min (p = 0.001). The right ventricular end-diastolic volume increased by 12% (p = 0.01) and end-systolic volume increased by 11% (p = 0.03). Stroke volume increased by 18% (p = 0.005). There was no significant correlation between the change in LVEF and the pre-amiodarone LVEF, the time interval between studies, or with indexes of amiodarone effect (change in heart rate, QRS, QTc, TSH, amiodarone dosage). In 5 patients (7%), LVEF decreased significantly, requiring discontinuation of amiodarone therapy in 1 patient. At the time of the second study congestive heart failure was manifest in 19%, and there was a trend suggesting that congestive heart failure was more likely if the initial LVEF was less than or equal to 35% (p = 0.10). Thus, amiodarone may rarely adversely affect contractility, although myocardial contractility is typically unchanged. There is an associated small increase in the size of both ventricles.     

Hemodynamic effects of acute atrioventricular sequential pacing in patients with left ventricular dysfunction

Acute atrioventricular (A-V) sequential pacing was compared with ventricular pacing in seven men with symptomatic left ventricular failure (New York Heart Association functional class III and IV) and depressed left ventricular ejection fraction (mean 29 percent, range 18 to 40). Cardiac index was higher during A-V sequential pacing than during ventricular pacing for every patient at paced rates of 75 to 100 beats/min. The mean increment was 17 percent (range 10 to 37) at a paced rate of 75 beats/ min, 23 percent (range 8 to 45) at a paced rate of 85 beats/min and 29 percent (range 19 to 55) at a paced rate of 100 beats/min. The increase in cardiac index in an individual patient did not correlate with baseline characteristics including functional class, cardiothoracic ratio, resting ejection fraction, cardiac index or balloon-occluded pulmonary wedge pressure.Arterial pressure varied from beat to beat during ventricular pacing because of the changing relation of atrial to ventricular systole. When an atrial contraction preceded a ventricular paced beat by a physiologic interval intraarterial pulse pressure uniformly increased. That increase correlated strongly (r = 0.993) with the increase in cardiac index that occurred during A-V sequential pacing. Measurement of the pulse pressure during A-V dissociation is a simple technique that may be useful for predicting the degree of improvement in cardiac output expected with methods of pacing that restore A-V synchrony.     

Effects of disopyramide on left ventricular function: Assessment by radionuclide cineangiography

To determine the effects of disopyramide on resting systolic left ventricular (LV) function and LV functional reserve, gated equilibrium radionuclide cineangiography was performed at rest and during maximal symptom-limited supine bicycle exercise in 12 patients after a single 300 mg oral loading dose of disopyramide, and in 22 patients (including the 12 patients just mentioned) after they received disopyramide 150 mg 4 times daily for 5 to 10 days (average 7). The oral loading dose (average serum level 3.6 ± 1.3 μg/ml [standard deviation]) produced decreases in ejection fraction in 9 of 12 patients with a decrease in average resting ejection fraction from 40 ± 15% to 33 ± 11% (p <0.005). However, the lower, sustained dosage of disopyramide was associated with a lower average serum level of 2.5 ± 0.8 μg/ml and with smaller but significant decreases in ejection fraction in 3 of 22 patients during exercise only. At this dosage there was no significant decrease in average ejection fraction for the group at rest or during exercise. Adverse effects of disopyramide on ejection fraction occurred even in patients with previously normal LV function at rest. Hence, disopyramide may be associated with significant decreases in LV systolic function, particularly when given in high, oral “loading” doses. However, sustained therapy with lower dosages as well as lower drug levels is also associated with less depression of LV function.     

Noninvasive diagnosis of left ventricular pseudoaneurysm: role of two dimensional echocardiography and radionuclide gated pool imaging.

This report describes a case of left ventricular pseudoaneurysm diagnosed with two dimensional real time echocardiography. The two dimensional echocardiogram identified not only the pseudoaneurysmal sac but also the site of left ventricular rupture. When supplemented with radioisotope gated cardiac blood pool scanning, the noninvasive studies demonstrated combined true and false left ventricular aneurysms. Left ventricular pseudoaneurysm can be diagnosed using two dimensional echocardiography and nuclear imaging, permitting early operative intervention before fatal rupture.     

Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dog

Encainide is highly effective in suppressing most nonsustained ventricular arrhythmias, but there is evidence that the drug is less effective and may worsen some arrhythmias, particularly in patients with sustained ventricular tachycardia. In most patients it is likely that the major antiarrhythmic effects of encainide are mediated through a potent metabolite, O-demethyl encainide. The effects of infusions of saline solution or O-demethyl encainide on spontaneous ventricular ectopic activity and ventricular fibrillation (VF) threshold were compared in 25 dogs with a mottled myocardial infarct produced by transient coronary occlusion. Plasma levels of the metabolite above 100 ng/ml suppressed (greater than 92%) the spontaneous ventricular ectopic activity that occurred 48 hours after MI, whereas saline solution had no effect. In 15 dogs treated with O-demethyl encainide, the VF threshold decreased an average of 23%, from a baseline level of 23 +/- 8 mA to 18 +/- 9 mA (p less than 0.05). There was a concentration-dependent fall in VF threshold with plasma concentrations of O-demethyl encainide above 150 ng/ml. In 2 dogs with very high plasma concentrations of the metabolite (greater than 1,000 ng/ml), VF was induced by right ventricular pacing alone (S1S1 300 ms). No change in VF threshold was observed in the 8 dogs treated with saline solution, and in each of these dogs VF could be terminated by the countershock protocol. However, in 7 of the 17 dogs treated with O-demethyl encainide, VF could not be terminated by the countershock protocol.(ABSTRACT TRUNCATED AT 250 WORDS)     

Relation of left ventricular mass to geometry of the proximal coronary arteries in the dog

Proximal epicardial coronary artery luminal diameters were measured from silicone casts formed in situ in freshly excised hearts under a constant pressure of 100 mm Hg. Twenty-five coronary arteries from 15 normal dogs and 22 coronary arteries in 13 dogs with either chronic pressure or volume overload hypertrophy were studied. Mean left ventricular (LV) body weight ratios were 4.75 ± 1.01 g/kg in the normal dogs, 8.4 ± 1.7 g/kg in the pressure-overload dogs, and 6.2 ± 0.6 g/kg in the volume-overload dogs. The cross-sectional area of the left circumflex (LC) coronary artery was determined at 11 branch sites. The ratio of the area of the branches to the area of the parent vessel was 1.095 ± 0.105, indicating that the cross-sectional area after a branch point increased.

A poor correlation existed between LV mass and coronary artery diameter in both normal and hypertrophy groups for the LC (r = 0.44), the left anterior descending (LAD) (r = 0.63), and the combined LC and LAD (r = 0.52). The mean cross-sectional area of the combined LC and LAD was 0.12 cm² in the normal group and 0.15 cm² in the hypertrophy group; this increase was not statistically significant (p = 0.13). When the mean cross-sectional area of the combined vessels was adjusted for heart weight, there was a decrease in the cross-sectional area/100 g of myocardium in the hypertrophy group compared with the control group. These data demonstrate that coronary artery luminal diameter in the dog does not increase commensurately with the increase in mass associated with myocardial hypertrophy.